NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Analyst Coverage

Firm Analyst
Bank of America / Merrill Lynch
Bob Hopkins
BTIG
Ryan Zimmerman
Canaccord Genuity
Kyle Rose
Cantor Fitzgerald
Craig Bijou
Cowen and Company
Josh Jennings
Credit Suisse
Matt Miksic
Jefferies & Company, Inc.
Raj Denhoy
JMP Securities
David Turkaly
JP Morgan
Robbie Marcus
Morgan Stanley
Jon Demchick
Needham and Company
Mike Matson
Piper Jaffray
Matthew O’Brien
RBC Capital Markets
Brendon Henry
Robert W. Baird & Co.
Jeff D. Johnson
SVB Leerink
Richard Newitter
UBS
Matt Taylor
Wells Fargo Securities
Larry Biegelson

Nuvasive Inc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Nuvasive Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Nuvasive Inc or its management. Nuvasive Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.